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Digestion of methylamine-treated a*-macroglobulin (c(,M.MA) with catalytic amounts of papain at pH 4.5 
has been investigated. Cleavage of Lys( 13 13)-Glu resulted in two major products, which could be separated 
by gel chromatograhy: a large disulfide bridged fragment set nearly the size of intact QM.MA, and an 18 
kDa fragment, constituting the carboxy-terminal domain of cczM. This domain contained the receptor recog- 
nition site. exposed as a result of cleavage of the internal B-cysteinyl-y-glutamyl thiol esters in cz*M. Com- 
pared with ?zM-trypsin complex the apparent affinity for binding to rat hepatocyte receptors was 0.1 and 
2% at 4 and 37 C. respectively. The receptor-binding domain presumably forms a compact globular b-bar- 
rel-type structure. stable at pH 2.5-9.0. Chemical modification experiments suggest that receptor binding 
is contributed by a determinant formed by the precise folding of the polypeptide chain. 
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1. INTRODUCTION 
azM-proteinase complex formation is initiated 
by specific limited proteolysis in the activation 
cleavage region (residues 681-686 [l]). This trig- 
gers a conformational change, resulting in the 
generation of tight-fitting binding sites for pro- 
teinases, one in each dimeric unit [2]. In addition, 
previously concealed recognition sites appear in 
LYZM, important for the rapid clearance of ~QM- 
proteinase complexes by receptor-mediated en- 
docytosis [3-81. Methylamine-inactivated cvzM is 
also rapidly cleared [3,7,8]. Using digestion with 
Abbreviations: cuzM, q-macroglobulin (human); cvzM. 
MA, cY2-macroglobulin treated with CH3NH2 and 
ICHzCONHz; EDC, ethyldimethylaminopropyl car- 
bodiimide; DTT, dithiothreitol; GuHCl; guanidinium 
chloride; cuzMT, cuz-macroglobulin-trypsin complex. 
an extracellular proteinase from Lysobacter en- 
zymogenes at pH 4.5 the receptor recognition site 
was recently localized to a domain containing the 
carboxy-terminal 138 residues [9], which also con- 
tains epitopes of neoantigens appearing after thiol 
ester cleavage [4, lo]. Here we report, in the course 
of probing the domain structure of ~YY~M by pro- 
teolytic digestion, that the same domain can be ob- 
tained in high yield by digestion with the readily 
available papain at pH 4.5. In addition, the effect 
on receptor binding by chemically modified ver- 
sions of the receptor-binding domain is reported. 
2. MATERIALS AND METHODS 
Human CYZM prepared as in [ 1 I] was treated with 
CH3NH2 and ICHzCONHz [ 121. Crystalline pa- 
pain was from Boehringer, Mannheim. SDS- 
PAGE was performed according to [I31 using 
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lo-2OYo gradient gels. Procedures for amino acid 
analysis and sequence determination were reported 
in [14]. Determination of binding of cu?M-trypsin 
complex to rat hepatocytes at 4”C, and uptake at 
37°C were done as in [15,16]. Lys residues in the 
receptor-binding domain were modified by suc- 
cinylation and citraconylation at pH 9.5 [171, Arg 
residues by reaction with 1 ,Zcyclohexanedione at 
pH 8.0 [18], and -COOH groups by reaction with 
EDC at pH 6.1 [ 191. All modified derivatives were 
soluble to at least 2 mg/ml at pH 7-8. 
Digestion of azM. MA (770 mg dissolved in 100 
ml of 0.1 M CHKOONa, pH 4.5) with papain (12 
mg dissolved in 6 ml of 0.1 M CHKOONa, 5 mM 
cysteine, pH 5.0) was carried out for 20 h at room 
temperature (S : E = 1: 0.3 mol/mol, equal to 64 : 1 
w/w). At the end of digestion Tris base was added 
and papain inactivated by addition of 1 ml of 0.5 
M IHC2CONH2 at pH 8.0. The digest was ana- 
lyzed by SDS-PAGE (fig. 1, inset) and 80% of the 
material separated by gel chromatography (fig. 1). 
The material in pool 1 (large fragment set) was 
dialyzed into 50 mM Tris-HCl, 0,l M NaCI, pH 
7.4, and concentrated by ultrafiltration (Amicon 
PM 10 membrane) to 34 mg/ml (assuming E (1 %, 
280 nm, 1 cm) = 9.0). The volume and the buffer 
concentration of the material in pool 2 (small frag- 
ment set) was reduced to one-fifth by ultrafiltra- 
tion. A subsequent DEAE-Sephacel step (not 
shown) using gradient elution with N&HCO3 
yielded a nearly symmetrical peak eluting between 
0.15 and 0.25 M NH4HC03. This material was 
dialyzed into the same Tris buffer and concen- 
trated to 4 mg/ml by ultrafiltration. Based on a 
content of 7 Phe residues and 4 Arg residues, and 
a molecular mass of 18 000 (see below) E (1 %, 280 
nm, 1 cm) was estimated at 5.5. The preparative 
yield was 50 mg (approx. 80%). 
3. RESULTS 
Although it has been recognized that WM. MA 
is very resistant owards proteinases [20] extensive 
fragmentation can be obtained using a 2-4-fold 
molar excess of trypsin, chymotrypsin, elastase, 
and papain (not shown). Using small amounts of 
papain a relatively limited digestion took place at 
pH 4.5 (fig.1). The material of low molecular mass 
separated by gel chromatography (pool 2, fig.1) 
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consisted of two major fragments (20 and 17 kDa, 
reducing conditions), while the remainder of 
a2M. MA (pool 1, fig.1) was a large disulfide 
bound set ot several fragments. At pH 4.5 and 
room temperature the small fragment set was near- 
ly completely released from UY~M - MA in 4-6 h at 
papain :cuzM. MA ratios ranging from 1: 20 to 
1: 80 (w/w). At pH 7.0 these fragments were only 
seen by using larger amounts of papain, which also 
resulted in a different and more extensive fragmen- 
tation of cu2M . MA (not shown). The following se- 
quence was obtained from the small fragment set 
in a purity of more than 95%: Glu-Glu-Phe-Pro- 
Phe-Ala-Leu-Gly-Val-Gln-Thr-Leu-Pro-, showing 
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Fig. 1. Gel chromatography of papain-digested CyZM -MA. 
A column of Sephacryl S-200 (5 x 107 cm) was equili- 
brated and eluted with 0.1 M NH~HCOJ, pH 8.2, at a 
flow rate of 100 ml/h. lo-ml fractions were collected and 
two pools (1 and 2) were made. In a parallel experiment 
where papain was not inactivated by reaction with 
ICHzCONHz activity measurements using N-benzoyl-L- 
arginine-p-nitroanilide showed that more than 95% of 
the papain used for digestion was associated with pool 1. 
Inset: SDS-PAGE analysis of papain-digested LYZM .MA 
and purified 18 kDa fragment. Lanes: 1 and 3, whole 
digest; 2 and 4, fragment set from pool 2; 3 and 4, DTT 
reduced samples. The position and size (kDa) of elec- 
trophoresis markers are indicated (reduced IYZM- 
subunit, plasminogen, albumin, ovalbumin, chymotryp- 
sinogen, ribonuclease). 
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that the major fragments arose by specific cleavage 
at Lys( 13 13)-Glu in a2M [ 11. Presumably they ex- 
tend to the carboxy-terminus of CQM as judged 
from agreement with the amino acid composition 
for the stretch 1314-1451 in CYZM:ASX 13.2 (14); 
Thr 7.4 (9); Ser 13.6 (15); Glx 13.7 (13); Pro 8.4 
(8); Gly 3.9 (4); Ala 9.5 (9); Val 12.6 (15); Cys 1.4 
(2); Met 2.3 (3); Ile 5.1 (6); Leu 12.7 (12); Tyr 5.9 
(6); Phe 7.4 (7); Lys 8.6 (8); His 2.6 (3); Arg 4.1 
(4). The molecular mass of this stretch is 1533 1. In- 
cluding carbohydrate bound to Asn-1401 [l] the 
molecular mass is estimated at 18 kDa. The ap- 
parent size of 20 kDa estimated from reducing 
SDS-PAGE is consistent with the anomalous 
behaviour of carbohydrate containing polypep- 
tides in this analysis. The fragments of apparent 
size 17 kDa and less probably represent minor 
variants, in which part of the carbohydrate bound 
to Asn-1401 is missing [1,9]. 
The large and the small fragment sets were tested 
for their ability to compete with 1251-cyzM-trypsin 
complex for binding to rat hepatocytes at 4°C. As 
seen from fig.2 the small fragment set was able to 
completely displace azM-trypsin from its hepato- 
cyte receptors. The affinity of this fragment for 
binding to the cu2M receptors was approx. 0.1% 
that of binding of cwzM-trypsin (apparent &-0.3 
PM vs 0.2 nM [15]). This figure is similar to that 
obtained for binding of the small fragment set to 
cvzM receptors in fibroblasts [9]. In uptake studies 
at 37°C (not shown) the potency was about 2% 
(apparent Km - 0.5 PM vs 10 nM). 
Incubation at pH 9.0, 3.5, and 2.5 for 20 h 
(room temperature) had no effect on the ability of 
the small fragment set to compete with lz51-azM- 
trypsin for binding. Incubation with pepsin (E:S 
= 1: 100 mol/mol, pH 2.5) for 1 h at room tem- 
perature had no effect on receptor binding, and se- 
quence analysis showed that the fragment was still 
intact. After incubation in 6 M GuHCl for 20 h 
(fig.2) or at pH 12.0 for 15 min approx. 10% of the 
receptor-binding activity was still present. In con- 
trast, the affinity of the small fragment set was 
reduced to less than 1% in samples that had been 
exposed to 50% HCOOH for 20 h, or had been 
reduced with DTE in the absence or presence of 
GuHCl. Succinylation of Lys residues and modifi- 
cation of -COOH groups by EDC also reduced 
receptor binding to less than 1 %, while modifica- 
tion of Arg residues by 1,Zcyclohexanedione had 
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Fig.2. Binding of “‘1-crzM-trypsin complex to rat hepa- 
tocytes in the presence of varying amounts of unlabelled 
a2M-trypsin, and fragments from pools 1 and 2 (fig.1). 
Hepatocytes (4 x lo5 in 250 ~1) were incubated with 30 
pM labelled complex (about 5000 cpm/tube) and un- 
labelled ligand as indicated for 20 h. The curves repre- 
sent the mean values of 4 independent experiments. The 
amount of tracer bound to the cells in the absence of 
unlabelled ligand varied from 16 to 25% in individual 
experiments, and binding is therefore expressed in per- 
cent of the control value. The small (18 kDa) fragment 
set was, relative to azM-trypsin, more effective in com- 
peting with the tracer at high than at low concentration. 
Its potency was calculated as 0.4x 10m3, i.e. 0.16% per 
a2M-trypsin subunit. This should be taken as an approx- 
imation since the competition curves were not parallel. 
no effect. No receptor binding could be demon- 
strated in a tryptic digest of citraconylated recep- 
tor-binding fragment containing the following 
peptides from (YZM in which the Lys residues had 
been deblocked at pH 1.5 for 6 h:1314-1350, 
1351-1378,1379-1384,1385-1417, and 1418-1451. 
In all experiments with modified versions of the 
small fragment set a concentration of 5-10pM was 
used. At this concentration essentially no binding 
of “‘I-cYzM-trypsin occurs in the presence of the 
native fragment set (fig.2). 
4. DISCUSSION 
The carboxy-terminal 138 residue fragment evi- 
dently constitutes a relatively stable domain, which 
can readily be separated from the remainder of 
auzM by cleavage at Lys( 13 13)-Glu at pH 4.5 as also 
observed recently [9]. Since this domain competes 
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effectively with m2M-trypsin complex for binding 
to hepatocytes, it presumably forms a discrete do- 
main in (YZM containing all structural information 
required for receptor recognition. However, the 
apparent affinity for receptor binding/uptake was 
only about O.l-2% that of a2M-trypsin complex, 
indicating that the receptor recognition domains 
(two in each dimeric proteinase binding unit [4]) 
may be uniquely positioned in intact cYzM-protein- 
ase complex for recognition by the cellular recep- 
tor. 
The receptor-binding domain of CQM is largely 
constituted by alternating P-strands and reverse 
turns, presumably forming a &barrel type of do- 
main [21]. This domain is stable in the pH range 
2.5-9.0 and is relatively tight as probed by its 
resistance to proteolytic digestion. However, re- 
duction of its internal disulfide bridge or exposure 
to 50% HCOOH leads to complete loss of receptor 
binding, indicating that the cellular receptor recog- 
nizes a determinant formed by the precise folding 
of the polypeptide chain in the domain. This is fur- 
ther substantiated by the lack of receptor binding 
of a mixture of relatively large tryptic peptides 
containing internal Lys residues covering the stretch 
1314-1451 in cu2M. Since modification of Lys, and 
Glu and Asp residues results in loss of binding af- 
finity, it is likely that the receptor-binding determi- 
nant is part of one or more external oops, presum- 
ably also containing hydrophobic residues. At pre- 
sent these cannot be unambiguously pointed out 
Pll. 
The site of cleavage (Lys( 13 13)-Glu) is located in 
a short hydrophilic stretch [l] connecting two do- 
mains of a2M (fig.3) and is exposed at pH 4.5. 
Although the exposure of the receptor recognition 
site in LYZM apparently is dependent on a confor- 
mational change effected by thiol ester cleavage 
the mechanism is not known. For transmitting 
conformational changes in the domain(s) control- 
ling the state of the thiol ester to the carboxy- 
terminal receptor-binding domain the disulfide 
bridge Cys(898)-Cys(1298) [l] (fig.3) could be im- 
portant by juxtaposing these domains in the native 
structure of cuzM. In view of the common ancestry 
of CYZM, C3 and C4 [22,23] it is possible that the 
domains in C3 and C4 corresponding to the recep- 
tor recognition domain in (YZM (fig.3) are impor- 
tant for recognition by one or more of the cellular 
receptors known to interact with activated C3 and 
C4 or their degradation products. Curiously, C3 
and C4 also contain a similarly located disulfide 
bridge originating from a position close to the thiol 
ester domain and spanning across several hundred 
residues in sequence [24,25]. 
The finding here that more than 95% of the pa- 
pain used for digestion of CYZM. MA was associated 
with the large fragment set (fig. 1, legend) confirms 
earlier reports showing that (YZM -MA slowly binds 
proteinases [20], and indicates that the small 
carboxy-terminal domain is not involved in form- 
ing the structures in a2M necessary for tight pro- 
teinase complex formation. 
The demonstration that receptor binding of CQM 
is confined to a discrete domain prompts further 
studies on the domain structure of CQM, particular- 
ly with regard to a more detailed understanding of 
its structural and functional relationship with the 
complement proteins C3 and C4. 
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